+

WO2008152398A3 - Formulations pour inhalation - Google Patents

Formulations pour inhalation Download PDF

Info

Publication number
WO2008152398A3
WO2008152398A3 PCT/GB2008/002029 GB2008002029W WO2008152398A3 WO 2008152398 A3 WO2008152398 A3 WO 2008152398A3 GB 2008002029 W GB2008002029 W GB 2008002029W WO 2008152398 A3 WO2008152398 A3 WO 2008152398A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhalation
formulations
propellant
polymer
optionally
Prior art date
Application number
PCT/GB2008/002029
Other languages
English (en)
Other versions
WO2008152398A2 (fr
Inventor
Arnar Lulla
Geena Malhotra
Original Assignee
Cipla Limited
Curtis, Philip, Anthony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Limited, Curtis, Philip, Anthony filed Critical Cipla Limited
Publication of WO2008152398A2 publication Critical patent/WO2008152398A2/fr
Publication of WO2008152398A3 publication Critical patent/WO2008152398A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention porte sur une formulation d'aérosol pharmaceutique comprenant un matériau actif enrobé d'un polymère en combinaison avec un propulseur, facultativement avec d'autres excipients pharmaceutiquement acceptables.
PCT/GB2008/002029 2007-06-14 2008-06-12 Formulations pour inhalation WO2008152398A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
IN1123MU2007 2007-06-14
IN1123/MUM/2007 2007-06-14
IN1249/MUM/2007 2007-06-29
IN1249MU2007 2007-06-29
IN1253/MUM/2007 2007-07-02
IN1253MU2007 2007-07-02

Publications (2)

Publication Number Publication Date
WO2008152398A2 WO2008152398A2 (fr) 2008-12-18
WO2008152398A3 true WO2008152398A3 (fr) 2009-11-12

Family

ID=39869725

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/002029 WO2008152398A2 (fr) 2007-06-14 2008-06-12 Formulations pour inhalation

Country Status (1)

Country Link
WO (1) WO2008152398A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0801876D0 (en) 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
CN103874483B (zh) 2011-10-11 2017-09-12 奇斯药制品公司 包衣了脂肪酸的β‑激动剂的晶体微粒
EP2877178A1 (fr) 2012-07-26 2015-06-03 Wockhardt Limited Composition pharmaceutique comprenant de la diamorphine destinée à une administration intranasale
MX2015003731A (es) * 2012-10-23 2015-06-15 Cipla Ltd Composicion farmaceutica.
EP3174522A1 (fr) 2014-07-29 2017-06-07 3M Innovative Properties Company Procédé de préparation d'une composition pharmaceutique
CN106551909A (zh) * 2015-09-23 2017-04-05 苏州欧米尼医药有限公司 一种高分散微细粉体颗粒的制备方法
CN110840864B (zh) * 2019-12-20 2022-02-22 广州健康元呼吸药物工程技术有限公司 一种β2受体激动剂吸入气雾剂及包含该吸入气雾剂的产品
CN117122564B (zh) * 2023-09-26 2024-05-14 海南卓科制药有限公司 一种氟尿嘧啶注射液及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034596A2 (fr) * 1997-02-07 1998-08-13 Minnesota Mining And Manufacturing Company Composes biocompatibles destines a des systemes d'apport de medicaments
WO1999038493A1 (fr) * 1998-01-30 1999-08-05 Rtp Pharma Inc. Formulations d'inhalation de microparticules
WO2002003958A1 (fr) * 2000-07-11 2002-01-17 Astrazeneca Ab Nouvelle preparation en aerosol contenant une molecule fluoree polaire
WO2003063843A1 (fr) * 2002-02-01 2003-08-07 Astrazeneca Ab Composition pour inhalation
US6641800B1 (en) * 1991-09-25 2003-11-04 Fisons Ltd. Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
WO2005055985A1 (fr) * 2003-12-10 2005-06-23 Medpharm Limited Preparations pour inhalation dosee de medicaments therapeutiques
WO2005056037A1 (fr) * 2003-12-10 2005-06-23 Medpharm Limited Preparations pour inhalation dosees de proteines et de peptides

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641800B1 (en) * 1991-09-25 2003-11-04 Fisons Ltd. Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
WO1998034596A2 (fr) * 1997-02-07 1998-08-13 Minnesota Mining And Manufacturing Company Composes biocompatibles destines a des systemes d'apport de medicaments
WO1999038493A1 (fr) * 1998-01-30 1999-08-05 Rtp Pharma Inc. Formulations d'inhalation de microparticules
WO2002003958A1 (fr) * 2000-07-11 2002-01-17 Astrazeneca Ab Nouvelle preparation en aerosol contenant une molecule fluoree polaire
WO2003063843A1 (fr) * 2002-02-01 2003-08-07 Astrazeneca Ab Composition pour inhalation
WO2005055985A1 (fr) * 2003-12-10 2005-06-23 Medpharm Limited Preparations pour inhalation dosee de medicaments therapeutiques
WO2005056037A1 (fr) * 2003-12-10 2005-06-23 Medpharm Limited Preparations pour inhalation dosees de proteines et de peptides

Also Published As

Publication number Publication date
WO2008152398A2 (fr) 2008-12-18

Similar Documents

Publication Publication Date Title
WO2008152398A3 (fr) Formulations pour inhalation
WO2008120207A3 (fr) Compositions pour administration nasale
WO2006101882A3 (fr) Formulations galeniques de medicaments, dispositifs et procedes associes
WO2007135193A3 (fr) Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
WO2007121318A3 (fr) Préparations destinées à l'administration d'insuline
WO2008109462A3 (fr) Compositions à libération prolongée utilisant des matières cireuses
WO2009062746A3 (fr) Médicaments topiques pour le traitement antimycotique
WO2010006143A3 (fr) Dispositif d'administration transdermique d'oestrogènes
WO2012022919A3 (fr) Formulations à base de nalbuphine et leurs utilisations
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
WO2009061607A3 (fr) Matières non miscibles à l'eau en tant que véhicules pour l'administration d'un médicament
WO2007047948A3 (fr) Administration intranasale d'insuline a action rapide
WO2006131931A3 (fr) Timbre transdermique pour la delivrance de medicaments
EP2109483A4 (fr) Masque de distribution d'aérosol
WO2010052466A8 (fr) Composition pharmaceutique en aérosol
EP1998751A4 (fr) Appareils, systèmes et méthodes pour administration d'un médicament
HK1101346A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
WO2008145348A3 (fr) Dispositif de distribution
WO2009043049A3 (fr) Formules pharmaceutiques
NZ612326A (en) Biodegradable drug delivery compositions
WO2012002640A3 (fr) Système transdermique d'administration de médicament contenant du donépézil
WO2010027405A3 (fr) Formulations solides stables de polypeptides agonistes vis-à-vis du récepteur gc-c se prêtant à une administration par voie orale
MX2013000642A (es) Composiciones farmaceuticas.
WO2010027404A3 (fr) Formulation stable de polypeptides thérapeutiques pour une administration par voie orale

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08762359

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2342/MUMNP/2009

Country of ref document: IN

122 Ep: pct application non-entry in european phase

Ref document number: 08762359

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载